Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Complaints Associated With Use of Pre-Filled Pen B When Used by Patients With Type 2 Diabetes on Twice-Daily Insulin Therapy

NCT00231725 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00231725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00231725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Complaints Associated With Use of Pre-Filled Pen B When Used by Patients With Type 2 Diabetes on Twice-Daily Insulin Therapy
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2005
Completion date
April 30, 2006
Enrollment
370
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus